CLINICAL_TRIALS trial_result · 2021-02-09

Clinical Trial Update: A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus [Phase 2]

Phase 2 trial assessing safety and efficacy of SAR425899 in adults with Type 2 Diabetes Mellitus has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-02-09